78 related articles for article (PubMed ID: 23843026)
21. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.
Brotherton JM; Mullins RM
Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834
[TBL] [Abstract][Full Text] [Related]
22. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
23. The impact of a universal human papilloma virus (HPV) vaccination program on lower genital tract dysplasia and genital warts.
Clark M; Jembere N; Kupets R
Prev Med; 2021 Sep; 150():106641. PubMed ID: 34048822
[TBL] [Abstract][Full Text] [Related]
24. Information needs of young women vaccinated against HPV attending colposcopy: a qualitative study.
Young A; Cotton S; Cruickshank ME
BMC Womens Health; 2018 Dec; 18(1):200. PubMed ID: 30541542
[TBL] [Abstract][Full Text] [Related]
25. Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.
Lang Kuhs KA; Porras C; Schiller JT; Rodriguez AC; Schiffman M; Gonzalez P; Wacholder S; Ghosh A; Li Y; Lowy DR; Kreimer AR; Poncelet S; Schussler J; Quint W; van Doorn LJ; Sherman ME; Sidawy M; Herrero R; Hildesheim A; Safaeian M;
Am J Epidemiol; 2014 Sep; 180(6):599-607. PubMed ID: 25139208
[TBL] [Abstract][Full Text] [Related]
26. Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial.
Hu SY; Kreimer AR; Porras C; Guillén D; Alfaro M; Darragh TM; Stoler MH; Villegas LF; Ocampo R; Rodriguez AC; Schiffman M; Tsang SH; Lowy DR; Schiller JT; Schussler J; Quint W; Gail MH; Sampson JN; Hildesheim A; Herrero R;
J Natl Cancer Inst; 2022 Sep; 114(9):1253-1261. PubMed ID: 35640980
[TBL] [Abstract][Full Text] [Related]
27. Will HPV vaccination prevent cervical cancer?
Rees CP; Brhlikova P; Pollock AM
J R Soc Med; 2020 Feb; 113(2):64-78. PubMed ID: 31962050
[TBL] [Abstract][Full Text] [Related]
28. Opportunities and challenges for human papillomavirus vaccination in cancer.
Roden RBS; Stern PL
Nat Rev Cancer; 2018 Apr; 18(4):240-254. PubMed ID: 29497146
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
30. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
Watson M; Benard V; King J; Crawford A; Saraiya M
Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575
[TBL] [Abstract][Full Text] [Related]
31. Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females.
Hirth JM; Lin YL; Kuo YF; Berenson AB
Prev Med; 2016 Jul; 88():134-9. PubMed ID: 27085993
[TBL] [Abstract][Full Text] [Related]
32. Self-reported human papillomavirus vaccination does not have an impact on the risk for high-grade cervical intraepithelial neoplasia among women referred for colposcopy.
Kuroki LM; Binder PS; Powell MA; Massad LS; Gao F
Am J Obstet Gynecol; 2016 Jul; 215(1):123-6. PubMed ID: 26944187
[No Abstract] [Full Text] [Related]
33. Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.
Berkowitz Z; Nair N; Saraiya M
Prev Med; 2016 Jun; 87():128-131. PubMed ID: 26921654
[TBL] [Abstract][Full Text] [Related]
34. A human papillomavirus vaccination program for low-income postpartum women.
Berenson AB; Rahman M; Hirth JM; Rupp RE; Sarpong KO
Am J Obstet Gynecol; 2016 Sep; 215(3):318.e1-9. PubMed ID: 26899907
[TBL] [Abstract][Full Text] [Related]
35. A Suggested Approach to Simplify and Improve Cervical Screening in the United States.
Schiffman M; Wentzensen N
J Low Genit Tract Dis; 2016 Jan; 20(1):1-7. PubMed ID: 26704326
[TBL] [Abstract][Full Text] [Related]
36. Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer.
Luckett R; Feldman S
Hum Vaccin Immunother; 2016 Jun; 12(6):1332-42. PubMed ID: 26588179
[TBL] [Abstract][Full Text] [Related]
37. Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.
Gonzalez P; Hildesheim A; Herrero R; Katki H; Wacholder S; Porras C; Safaeian M; Jimenez S; Darragh TM; Cortes B; Befano B; Schiffman M; Carvajal L; Palefsky J; Schiller J; Ocampo R; Schussler J; Lowy D; Guillen D; Stoler MH; Quint W; Morales J; Avila C; Rodriguez AC; Kreimer AR;
Vaccine; 2015 Apr; 33(18):2141-51. PubMed ID: 25796338
[TBL] [Abstract][Full Text] [Related]
38. Response.
Gage JC; Schiffman M; Katki HA; Castle PE; Fetterman B; Wentzensen N; Poitras NE; Lorey T; Cheung LC; Kinney WK
J Natl Cancer Inst; 2015 Jan; 107(1):390. PubMed ID: 25542966
[No Abstract] [Full Text] [Related]
39. Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women's Health Study.
Wadhera P; Evans JL; Stein E; Gandhi M; Couture MC; Sansothy N; Sichan K; Maher L; Kaldor J; Page K; ; Kien
Int J STD AIDS; 2015 Oct; 26(12):893-902. PubMed ID: 25505042
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
